相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Clinical Laboratory Detection of AmpC β-Lactamase Does It Affect Patient Outcome?
Kenneth H. Rand et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Quinolone resistance in Escherichia coli from Accra, Ghana
Sreela S. Namboodiri et al.
BMC MICROBIOLOGY (2011)
In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations
Lorenzo Drago et al.
BMC MICROBIOLOGY (2010)
Increased fluoroquinolone resistance with time in Escherichia coli from > 17,000 patients at a large county hospital as a function of culture site, age, sex, and location
Lauren Becnel Boyd et al.
BMC INFECTIOUS DISEASES (2008)
Extended-spectrum beta-lactamase-producing enterobacteriaceae: an emerging public-health concern
Johann D. D. Pitout et al.
LANCET INFECTIOUS DISEASES (2008)
Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens
Hafizah Y. Chenia et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
The CTX-M β-lactamase pandemic
Rafael Canton et al.
CURRENT OPINION IN MICROBIOLOGY (2006)
Extended-spectrum β-lactamases and clinical outcomes:: Current data
R Ramphal et al.
CLINICAL INFECTIOUS DISEASES (2006)
Bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae:: Risk factors, molecular epidemiology, and clinical outcome
M Tumbarello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Evolution of CTX-M-type β-lactamases in isolates of Escherichia coli infecting hospital and community patients
G Brigante et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
First isolation of bla(VIM-2) in Klebsiella oxytoca clinical isolates from Portugal
T Conceicao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients
J Rodríguez-Baño et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Extended-spectrum β-lactamase-producing Enterobacteriaceae in community and private health care centers
C Arpin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Imipenem-EDTA disk method for differentiation of metallo-β-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp.
DE Yong et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Broad resistance due to plasmid-mediated AmpC β-lactamases in clinical isolates of Escherichia coli
R Odeh et al.
CLINICAL INFECTIOUS DISEASES (2002)
Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime
A Wong-Beringer et al.
CLINICAL INFECTIOUS DISEASES (2002)
Plasmid-determined AmpC-type beta-lactamases
A Philippon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Extended-spectrum β-lactamases in the 21st century:: Characterization, epidemiology, and detection of this important resistance threat
PA Bradford
CLINICAL MICROBIOLOGY REVIEWS (2001)
Controversies about extended-spectrum and AmpC beta-lactamases
KS Thomson
EMERGING INFECTIOUS DISEASES (2001)
分享论文
